Live feed
Filing
SC 13G/A
SC 13G/A0001085146-18-000936·Correvio Pharma Corp.
Schedule 13G ownership disclosure
CARDIOME PHARMA CORP
Security class unavailable · CUSIP: 14159U301
Event date: 2018-02-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,370,913
- Percent of class
- 12.6200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-18-000936
- Form type
- SC 13G/A
- Filer
- Correvio Pharma Corp.
- CIK
- CIK 1036141
- Filed
- Mar 02, 2018
- Reporting period
- Feb 28, 2018
- Description
- Schedule 13G beneficial ownership